Addition of AEG35156 XIAP Antisense Oligonucleotide in Reinduction Chemotherapy Does Not Improve Remission Rates in Patients With Primary Refractory Acute Myeloid Leukemia in a Randomized Phase II Study

An evaluation of combinations of diaziquone, etoposide and mitoxantrone in the treatment of adults with relapsed or refractory acute myeloid leukemia: results of 8722, a randomized phase II study conducted by Cancer and Leukemia Group B

Leukemia ◽

10.1038/sj.leu.2400905 ◽

1998 ◽

Vol 12 (2) ◽

pp. 139-143 ◽

Cited By ~ 9

Author(s):

EJ Lee ◽

SL George ◽

PC Amrein ◽

PA Paciucci ◽

SL Allen ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

Randomized Phase Ii ◽

Group B ◽

Leukemia Group ◽

A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia

European Journal Of Haematology ◽

10.1111/ejh.13544 ◽

2020 ◽

Author(s):

Jonathan Canaani ◽

Ivetta Danylesko ◽

Noga Shemtov ◽

Maya Zlotnick ◽

Kira Lozinsky ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

A Phase II Study of CLAG Regimen Combined With Imatinib Mesylate for Relapsed or Refractory Acute Myeloid Leukemia

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2017.09.007 ◽

2017 ◽

Vol 17 (12) ◽

pp. 902-907 ◽

Cited By ~ 3

Author(s):

Abu-Sayeef Mirza ◽

Jeffrey E. Lancet ◽

Kendra Sweet ◽

Eric Padron ◽

Javier Pinilla-Ibarz ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Imatinib Mesylate ◽

Phase Ii ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

PF261 A RANDOMIZED, OPEN-LABEL, PHASE II STUDY OF SELINEXOR VERSUS PHYSICIAN'S CHOICE (PC) IN OLDER PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML)

HemaSphere ◽

10.1097/01.hs9.0000559256.03686.3a ◽

2019 ◽

Vol 3 (S1) ◽

pp. 82-83 ◽

Cited By ~ 1

Author(s):

K. Sweet ◽

W. Blum ◽

H. Donner ◽

I. Flinn ◽

O. Frankfurt ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Older Patients ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

Open Label ◽

Open Label Phase ◽

A 2:1 randomized, open-label, phase II study of selinexor vs. physician’s choice in older patients with relapsed or refractory acute myeloid leukemia

Leukemia & Lymphoma ◽

10.1080/10428194.2021.1950706 ◽

2021 ◽

pp. 1-12

Author(s):

Kendra Sweet ◽

Bhavana Bhatnagar ◽

Hartmut Döhner ◽

Will Donnellan ◽

Olga Frankfurt ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Older Patients ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

Open Label ◽

Open Label Phase ◽

A Pilot Phase II Study of the Feasibility and Efficacy of Vincristine Sulfate Liposome Injection in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Journal of Hematology ◽

10.14740/jh771 ◽

2021 ◽

Vol 10 (1) ◽

pp. 1-7

Author(s):

Mary Beth Seegars ◽

Ryan Woods ◽

Leslie R. Ellis ◽

Rupali Roy Bhave ◽

Dianna S. Howard ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

Pilot Phase ◽

Vincristine Sulfate ◽

Randomized phase II study of clofarabine versus clofarabine plus low-dose cytarabine (ara-C) for patients (pts) ≥ 60 years (yrs) with newly diagnosed acute myeloid leukemia (AML)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.6627 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 6627-6627 ◽

Cited By ~ 2

Author(s):

S. Faderl ◽

F. Ravandi-Kashani ◽

A. Ferrajoli ◽

Z. Estrov ◽

W. Wierda ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Myeloid Leukemia ◽

Low Dose ◽

Phase Ii Study ◽

Newly Diagnosed ◽

Randomized Phase Ii ◽

Low Dose Cytarabine ◽

A Phase II Study of Lenalidomide Alone in Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes With Chromosome 5 Abnormalities

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2012.04.001 ◽

2012 ◽

Vol 12 (5) ◽

pp. 341-344 ◽

Cited By ~ 23

Author(s):

Yiming Chen ◽

Hagop Kantarjian ◽

Zeev Estrov ◽

Stefan Faderl ◽

Farhad Ravandi ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Phase Ii ◽

Myelodysplastic Syndromes ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

Chromosome 5 ◽

A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG)

European Journal Of Haematology ◽

10.1034/j.1600-0609.2003.00122.x ◽

2003 ◽

Vol 71 (3) ◽

pp. 155-162 ◽

Cited By ~ 36

Author(s):

A. Wrzesień-Kuś ◽

T. Robak ◽

E. Lech-Marańda ◽

A. Wierzbowska ◽

A. Dmoszyńska ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Induction Therapy ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

Adult Leukemia ◽

Leukemia Group ◽

Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia

Leukemia Research ◽

10.1016/j.leukres.2017.09.005 ◽

2017 ◽

Vol 61 ◽

pp. 108-116 ◽

Cited By ~ 16

Author(s):

Jonathan A. Webster ◽

Raoul Tibes ◽

Larry Morris ◽

Amanda L. Blackford ◽

Mark Litzow ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Cytosine Arabinoside ◽

Myeloid Leukemia ◽

Phase Ii Trial ◽

Randomized Phase Ii ◽

Chk1 Inhibitor ◽